3-Acetylpyridine-Adenine Dinucleotide
Modify Date: 2025-08-25 21:20:49
3-Acetylpyridine-Adenine Dinucleotide structure
|
Common Name | 3-Acetylpyridine-Adenine Dinucleotide | ||
|---|---|---|---|---|
| CAS Number | 102029-93-6 | Molecular Weight | 708.42 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H28N6Na2O14P2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 3-Acetylpyridine-Adenine Dinucleotide3-Acetylpyridine adenine dinucleotide (disodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1-(1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinyl)ethanone, disodium salt (9CI) |
|---|
| Description | 3-Acetylpyridine adenine dinucleotide (disodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Molecular Formula | C22H28N6Na2O14P2 |
|---|---|
| Molecular Weight | 708.42 |
| Exact Mass | 662.113892 |
| PSA | 311.22000 |
| LogP | -7.96 |
| InChIKey | MVUPSUBZLWXBQB-UHFFFAOYSA-L |
| SMILES | CC(=O)C1=CN(C2OC(COP(=O)([O-])OP(=O)([O-])OCC3OC(n4cnc5c(N)ncnc54)C(O)C3O)C(O)C2O)C=CC1.[Na+].[Na+] |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| RIDADR | NONH for all modes of transport |
|
Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.
Malaria Journal 14 , 213, (2015) The discovery of malaria transmission-blocking compounds is seen as key to malaria elimination strategies and gametocyte-screening platforms are critical filters to identify active molecules. However,... |
|
|
A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs.
J. Antimicrob. Chemother. 70 , 1357-66, (2015) The development of drugs to reduce malaria transmission is an important part of malaria eradication plans. We set out to develop and validate a combination of new screening assays for prioritization o... |